Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026)
Owlet (OWLT) reported Net Income towards Common Stockholders of -$4.1 million for Q1 2026, down 336.96% year-over-year from $1.7 million in Q1 2025, and up 58.15% quarter-over-quarter from -$9.9 million in Q4 2025.
Owlet (OWLT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$4.1 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$4.1 million, down 336.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$48.6 million (down 179.48% YoY), and the FY2025 annual result was -$41.9 million, down 143.1% from the prior year.
- Net Income towards Common Stockholders climbed to -$4.1 million in Q1 2026 per OWLT's latest filing, from -$9.9 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $2.7 million in Q3 2025 and troughed at -$37.2 million in Q2 2025.
- A 5-year average of -$10.7 million and a median of -$9.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 139.61% in 2025 and fell as far as 1286.54% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$19.5 million in 2022, then jumped by 57.85% to -$8.2 million in 2023, then decreased by 17.8% to -$9.7 million in 2024, then fell by 2.23% to -$9.9 million in 2025, then soared by 58.15% to -$4.1 million in 2026.
- Business Quant data shows OWLT's Net Income towards Common Stockholders at -$4.1 million in Q1 2026, -$9.9 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | -4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -9.90 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | -37.19 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -6.76 Mn |
| Jun 30, 2024 | -2.68 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | -8.22 Mn |
| Sep 30, 2023 | -6.96 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -12.52 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -19.36 Mn |
| Jun 30, 2022 | -11.72 Mn |
| Mar 31, 2022 | -28.76 Mn |
| Dec 31, 2021 | -24.06 Mn |
| Sep 30, 2021 | -34.46 Mn |
| Jun 30, 2021 | -5.34 Mn |